S9-CMC1 TFA is a covalent peptide lysine-specific demethylase 1 (LSD1) inhibitor with an IC50 value of 2.53 µM. S9-CMC1 TFA specifically recognizes Cys360 in the enzyme-active region. S9-CMC1 TFA inhibits LSD1 activity, increasing H3K4me1 and H3K4me2 levels, leading to G1 cell cycle arrest and apoptosis and inhibiting cell proliferation. S9-CMC1 TFA significantly inhibits tumor growth in A549 xenograft animal models[1].
Molecular Weight:
2158.57
Formula:
C97H151F3N32O17S2
Target:
Apoptosis,Histone Demethylase
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
